Stuka Paul's Form 4 filing
InspireMD, Inc. (NSPR) · filed Nov 30, 2021
- Accession no.
- 0001493152-21-030119
- Filed
- Nov 30, 2021
- Trade date
- Nov 29-30, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $76.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stuka PaulCIK 0001528577 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Common Stock | PPurchaseAcquired | +3,177 | $3.55 | +$11,278.35 | 43,125 | Indirect | |
| Nov 30, 2021 | Common Stock | PPurchaseAcquired | +18,372 | $3.55F2 | +$65,220.6 | 61,497 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.50 to $3.55, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Referenced by the price of 1 transaction in Table I.